​

Funding Round

Series A - Protillion Biosciences

Series A - Protillion Biosciences

Investment Firm

Overview

Protillion Biosciences specializes in the design and development of protein-based drugs.

Announced Date

Dec 19, 2022

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

ARCH Venture Partners

ARCH Venture Partners

ARCH Venture Partners is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Illumina Ventures

Illumina Ventures

Illumina Ventures is a debt and early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

2

Investor Name
Participant InvestorIllumina Ventures
Participant InvestorARCH Venture Partners

Round Details and Background

Protillion Biosciences raised $18000000 on 2022-12-19 in Series A

Protillion Biosciences specializes in the design and development of protein-based drugs.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 19, 2022
Series A - Protillion Biosciences
2-18.0M

Recent Activity

There is no recent news or activity for this profile.